Conversely, loss of NF2 and Tp53 are associated with the sarcomatoid subtype in human MPM (Bueno et al., 2016; Zhang et al., 2021), yet our model, which incorporates both of these tumour suppressors, yielded epithelioid tumours. The gene discussed is NF2; the disease is neoplasm.